Online Doctor Consultation & Medicines
Back ArrowBack Arrow
Offer IconSpecial offers
  1. Home
  2. BHARGLOB 16.5% INJECTION

BHARGLOB 16.5% INJECTION

Manufacturer

BHARAT SERUMS & VACCINES LTD

Composition

HUMAN NORMAL IMMUNOGLOBULIN-16.5%W/V

Pack Of

1 INJECTION

In Stock

Prescription Required
Product Details

About BHARGLOB 16.5% INJECTION

BHARGLOB 16.5% INJECTION belongs to the class of medications called ‘immunising agents’ used to treat immunoglobulin (antibody) deficiency and certain inflammatory disorders. It is used to treat immunoglobulin deficiency in people with primary immunodeficiency’s or PID (present from birth) and secondary immunodeficiency or SID (developed in the later stages of life). BHARGLOB 16.5% INJECTION is also used to treat inflammatory disorders such as primary immune thrombocytopenia (reduced number of platelets), Guillain-Barre syndrome (short-term inflammation of the peripheral nerves causing weakness of legs and upper limbs), Kawasaki disease (inflammation of blood vessels in children), chronic inflammatory demyelinating polyneuropathy or CIDP (long-term inflammation of peripheral nerves), and multifocal motor neuropathy (progressive disease leading to weakness of arms and legs).

BHARGLOB 16.5% INJECTION contains ‘Human normal immunoglobulin’, which replaces the deficient antibodies necessary to act against infections and inflammation. It works exactly as the immunoglobulins present in the body. Immunoglobulins are an essential part of the immune system which recognises the antigens or foreign elements in the body and aids in their destruction. It also helps to reduce inflammation by improving immunity.

It would be best if you took BHARGLOB 16.5% INJECTION precisely as prescribed by your doctor. BHARGLOB 16.5% INJECTION may cause side-effects such as swelling or hardening at the injection site and headache, pain in the face, back, arms, legs, joints, or neck, fever, flu-like illness (runny nose and sore throat), blisters in the mouth, and throat, and throat tightness. These side-effects are usually mild and temporary. However, if any of the side-effects persist or get worse, inform your doctor immediately.

It is not recommended to take BHARGLOB 16.5% INJECTION if you are allergic to any of its contents, or have blood clotting disorders. Before taking BHARGLOB 16.5% INJECTION, inform your doctor if you had any vaccinations recently, or have already had this product recently. BHARGLOB 16.5% INJECTION should be used with caution in people with immunoglobulin A (IgA) deficiency (IgA is a type of antibody that protects against infections). BHARGLOB 16.5% INJECTION is probably safe when given to children, pregnant women, and breastfeeding mothers. BHARGLOB 16.5% INJECTION should be used with caution in elderly people. BHARGLOB 16.5% INJECTION may not interact with alcohol. BHARGLOB 16.5% INJECTION may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.

Uses of BHARGLOB 16.5% INJECTION

Immunoglobulin deficiency and inflammatory disorders such as primary immune thrombocytopenia, Guillain-Barre syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.

Directions for Use

BHARGLOB 16.5% INJECTION is available in the form of injection or infusion. A trained healthcare professional will give you the BHARGLOB 16.5% INJECTION injection or infusion; so do not self-administer. BHARGLOB 16.5% INJECTION injection is given subcutaneously (under the skin), whereas infusion is given via intravenous (into the vein) route.

Storage

Store in a cool and dry place away from sunlight

Side Effects of BHARGLOB 16.5% INJECTION

  • Swelling or hardening at the injection site
  • Headache
  • Pain in the face, back, arms, legs, joints, or neck
  • Fever
  • Flu-like illness (runny nose and sore throat)
  • Blisters in the mouth and throat
  • Throat tightness

In-Depth Precautions and Warning

Drug Warning

BHARGLOB 16.5% INJECTION should be used with caution in people with immunoglobulin A (IgA) deficiency (IgA is a type of antibody that protects against infections) as there is an increased risk of allergic reactions. BHARGLOB 16.5% INJECTION may cause a sudden fall in blood pressure with an allergic reaction, including shock, even in patients who have tolerated previous treatment with this medicine. So, it is advised to monitor patients during infusion and at least 20 min after the infusion. If you develop a severe headache, drowsiness, fever, neck stiffness, sensitivity to light, nausea, and vomiting after BHARGLOB 16.5% INJECTION infusion, inform your doctor immediately. It may be a sign of aseptic meningitis syndrome (severe inflammation of the brain's linings). BHARGLOB 16.5% INJECTION should be used with caution in people with obesity or overweight, diabetes, high blood pressure (hypertension), hypovolemia (low blood volume), and blood clotting disorders, as there is a risk of developing a blood clot (very rare effect of BHARGLOB 16.5% INJECTION). So, inform your doctor if you notice any sign of a blood clot such as pain, swelling and unusual warmth of a limb, weakness on one side of the body, confusion, sudden shortness of breath, chest pain worsening on deep breathing, and difficulty speaking. BHARGLOB 16.5% INJECTION should be used with caution in patients with kidney problems or who have taken medicines that may harm kidneys (nephrotoxic drugs) as BHARGLOB 16.5% INJECTION may cause problems with kidney function in these people. In very rare cases, BHARGLOB 16.5% INJECTION may cause non-cardiogenic pulmonary oedema (accumulation of fluid in the lungs' air spaces, which is a non-heart related condition). In such cases, patients may experience breathing difficulty, bluish skin, and very low oxygen levels in the blood.

Safety Advice

  • Alcohol

    BHARGLOB 16.5% INJECTION may not interact with alcohol. However, It is best to avoid alcohol while taking medication.

  • Pregnancy

    BHARGLOB 16.5% INJECTION is probably safe when used in pregnant women.

  • Breast Feeding

    BHARGLOB 16.5% INJECTION is probably safe when used in breastfeeding women.

  • Driving

    BHARGLOB 16.5% INJECTION may cause dizziness, so do not drive or operate heavy machinery if you feel dizzy.

  • Liver

    BHARGLOB 16.5% INJECTION should be used with caution in patients with liver diseases. The dose may have to be adjusted by your doctor.

  • Kidney

    BHARGLOB 16.5% INJECTION should be used with caution in patients with kidney diseases. The dose may have to be adjusted by your doctor.

Other Information (BHA0002)

This item is Not Returnable.

Expires on or after - September 2021

Patients Concern

FAQs

The BHARGLOB 16.5% INJECTION contains 'Human normal immunoglobulin' which helps restore the deficient immunoglobulins or antibodies in the body. Antibodies are an essential part of the immune system that helps to reduce infection and inflammation. They act by identifying, attacking, and thereby destroying the antigen or foreign body that has entered or present in the body.

BHARGLOB 16.5% INJECTION may alter some blood test results for a certain time, so inform your doctor that you have BHARGLOB 16.5% INJECTION before undergoing blood tests. It is not recommended to take any vaccines (especially live vaccines) at least three months after taking BHARGLOB 16.5% INJECTION as this medicine may make the vaccines less effective.

BHARGLOB 16.5% INJECTION should be used with caution in patients with diabetes if this medicine is given as infusion as it may alter blood sugar levels. BHARGLOB 16.5% INJECTION doesn’t contain sugar; however, it can be diluted in a special sugar solution before giving the infusion.

BHARGLOB 16.5% INJECTION is usually well-tolerated. However, some patients may experience side-effects such as swelling or hardening at the injection site and headache, pain in the face, back, arms, legs, joints, or neck, fever, flu-like illness (runny nose and sore throat), blisters in the mouth, and throat, and throat tightness. If any of the side-effects persist or get worse, inform your doctor immediately.

It is a condition in which there is a decrease in antibody levels in the body due to decreased ability or inability to produce enough antibodies. It can be present from birth (primary) or acquired during the later stages of life (secondary).

BHARGLOB 16.5% INJECTION

BHARGLOB 16.5% INJECTION

MRP: 797.64

Vial
1

2 ml Injection in 1 Vial